Cellective BioTherapy
Cellective BioTherapy develops novel cellular and monoclonal antibody-based platforms to treat cancer, autoimmunity, and immunodeficiency.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Cellective BioTherapy Information
Geographic Data
Address:
City: Raleigh
State: North Carolina
Zip:
Country: United States
Financial Info
Stage:
angel
Raised Last:
$3M
Raised Total:$3M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cellective BioTherapy develops novel cellular and monoclonal antibody-based platforms to treat cancer, autoimmunity, and immunodeficiency. The biotechnology company focuses on the research and development of B cell-based cellular therapies for immunomodulation, immunodeficiency, and autoimmunity. It researches treatment for cancers, diabetes, asthma, and congenital and acquired immunodeficiency, and vaccine development.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2015 | Angel Round | 1 | $2.5M |
Eshelman Ventures Eshelman Ventures |
1/2004 | Venture Round | 1 | - |
Sofinnova Investments Sofinnova Investments |
1/2004 | Venture Round | 1 | - |
Sofinnova Investments Sofinnova Investments |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
